Adverum Biotechnologies
Adverum is a gene therapy company committed to discovering and developing novel medicines to patients living with rare diseases and diseases of the eye.
All edits by Sudhir Sikriwal
Edits on 18 Feb, 2021
Sudhir Sikriwal
Edits made to:
Article (+13/-13 characters)
Article
On April 22, 2014 Adverum Biotechnologies completed their series B funding roundfunding round with $55 million in capital from Venrock (lead investor), Sabby Capital, Rock Springs Capital, Redmile Group, Deerfield, and Adage Capital management.
Find more companies like Adverum Biotechnologies
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
